Evaluation of the prebiotic effect of hydrolates on Staphlylococcus spp. present in the skin microbiota
Article Sidebar
Main Article Content
Abstract
By synthesizing secondary metabolites, also known as active ingredients, which can act differently on other living beings, they are increasingly attracting the interest of the pharmaceutical and cosmetic industries, since they can develop formulations containing prebiotics, substances that help in the control of the cutaneous microbiome. In this work, the prebiotic effects of rosemary, lemongrass, lemongrass, lavender and mint hydrolates were evaluated. The growth rate of the Staphlylococcus aureus (S. aureus) strain was significantly lower (* p <0.05), when compared to the Staphlylococcus epidermidis (S. epidermidis) strain, after treatment with rosemary, mint and herb hydrolates lemon balm. Regarding the results of co-cultivation, it was observed qualitatively that the strain of S. aureus failed to achieve satisfactory growth in the presence of S. epidermidis associated with hydrolates, since the "turning point" of mannitol agar was not reached fully, suggesting that these by-products from the extraction of essential oils may have a prebiotic effect.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright Statement - Policy Proposal for Open Access Journals
Authors who publish in The Brazilian journal of Biomedical Sciences (RBCBM) agree to the following terms: 1 - Authors retain the copyright and grant the journal the right to first publication, with the work simultaneously licensed under the Creative Commons Attribution License allowing sharing of the work with recognition of the authorship of the work and initial publication in this journal. 2 - Authors are authorized to assume additional contracts separately, for non-exclusive distribution of the version of the work published in this journal (eg, publishing in institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal. 3 - Authors are allowed and encouraged to publish and distribute their work online (eg in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes, as well as increase the impact and citation of published work.
This is an open access article under the CC-BY license
(http://creativecommons.org/licenses/by/4.0)
References
2- ARAÚJO, J.C.L.V.; LIMA, E.O.; CEBALLOS, B.S.O.; FREIRE, K.R.L.; SOUZA, E.L.; SANTOS FILHO, L. Ação antimicrobiana de óleos essenciais sobre microrganismos potencialmente causadores de infecções oportunistas. Rev. Patol. Trop. 33: 55-64, 2004.
3- SIQUI, A.C.; SAMPAIO, A.L.F.; SOUSA, M.C.; HENRIQUES, M.G.M.O.; RAMOS, M.F.S. Óleos essenciais - potencial anti-inflamatório. Biotecnologia, Ciência e Desenvolvimento 16: 38-43, 2000.
4- MORO, G.; ARSLANOGLU, S.; STAHL, B. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch Dis Child. 91:814–819, 2006.
5- GRUBER C, VAN STUIJVENBERG M, MOSCA F, et al. Reduced occurrence of early atopic dermatitis because of immunoactive prebiotics among low-atopy-risk infants. J Allergy Clin Immunol. 126:791–797,2010.
6- KANTOR, R., & SILVERBERG, J. I. Environmental risk factors and their role in the management of atopic dermatitis. Expert review of clinical immunology, 13(1), 15–26, 2017. https://doi.org/10.1080/1744666X.2016.1212660
7- SIMMERING R, BREVES R. Pre- and probiotic cosmetics. Hautarzt. 60(10):809-14, 2009. doi: 10.1007/s00105-009-1759-4.
8- MARLIES, W.; CARSTEN, L.; FRANS, C. The Danish Environmental Protection Agency/ Survey of cosmetic products with "probiotic" or "prebiotic" claims. Survey of chemical substances in consumer products No. 171 November 2018.
9- ANGÉLICO, E.C.; COSTA, J.G.M.; GALVÃO, F.F.R.; SANTOS, F.O..; RODRIGUES, O.G. Composição química do óleo essencial das folhas de Croton heliotropiifolius Kant (Sinônimo C. rhamnifolius): resultados preliminares. Revista de Biologia e Farmácia, 7(1), 2012.
10. KAUR N., CHEN C.-C., LUTHER J., KAO J.Y. Intestinal dysbiosis in inflammatory bowel disease. Gut Microbes. 2011; 2:211–216. doi: 10.4161/gmic.2.4.17863
11. GRICE E.A., SEGRE J.A. The human microbiome: Our second genome. Annu. Rev. Genomics Human Genet. 2012; 13:151–170. doi: 10.1146/annurev-genom-090711-163814.
12. REN T., GLATT D.U., NGUYEN T.N., et al. 16 S rRNA survey revealed complex bacterial communities and evidence of bacterial interference on human adenoids. Environ. Microbiol. 2013; 15:535–547. doi: 10.1111/1462-2920.12000.
13. IWASE T., UEHARA Y., SHINJI H., TAJIMA A., et al. Staphylococcus epidermidis Esp. inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature. 2010; 465:346. doi: 10.1038/nature09074.
14. NAIK S., BOULADOUX N., WILHELM C., et al. Compartmentalized control of skin immunity by resident commensals. Science. 2012; 337:1115–1119. doi: 10.1126/science.1225152.
15. W. E. KLOOS, M. S. MUSSELWHITE. Distribution and persistence of Staphylococcus and Micrococcus species and other aerobic bacteria on human skin. Appl. Microbiol. 30, 381–385 (1975).
16. A. L. BYRD, C. DEMING, S. K. B. CASSIDY, O. J. HARRISON, et. al. Staphylococcus aureus and Staphylococcus epidermidis strain diversity underlying pediatric atopic dermatitis. Sci. Transl. Med. 9, eaal4651 (2017).
17. T. NAKATSUJI, T. H. CHEN, S. NARALA, K. A. CHUN, A. M. TWO, et al. Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis. Sci. Transl. Med. 9, eaah4680 (2017)
18. A. ZIPPERER, M. C. KONNERTH, C. LAUX, et al. Human commensals producing a novel antibiotic impair pathogen colonization. Nature 535, 511–516 (2016).